bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-70-0061

Order Name:
HPV Genotype (Cervix)

 
Useful For:
Use for the detection of human papillomaviruses DNA of 19 high-risk and 9 low-risk types in liquid based cytology
 
Methodology:
Multiplex real-time polymerase chain reaction (PCR) and Melting Temperature Analysis
 
AliasesName:
Human Papillomavirus (HPV) Genotyping
HPV (Human Papillomavirus) PCR
High Risk HPV
Low Risk HPV
 
 
 
Test Code:
090-70-0061

Order Name:
HPV Genotype (Cervix)

 
Collection Specimen Or Container:
Cervical cells/ PreservCyt® (ThinPrep liquid PAP vial) 20 mL, 1 vial
 
Specimen Testing Type:
Cervical cells in PreservCyt®solution, minimum volume 3 mL
 
Sub Mission Container:
Plastic tube
 
Rejection Criteria:
Specimen volume less than 3 mL will be reject.
 
Specimen Stabillity:
Specimen Type Temperature Time
Cervical cells in PreservCyt®solution Room temperature or Refrigerated, 2oC to 8oC 90 days
 
 
 
Test Code:
090-70-0061

Order Name:
HPV Genotype (Cervix)

 
Method detail:
Multiplex real-time polymerase chain reaction (PCR) and Melting Temperature Analysis
 
Schedule:
Thursday and Sunday, at 09:00 a.m.
 
Turnaround Time:
Received specimen to reported within 4 days.
 
Performing Location:
Molecular biology & Genetics, Laboratory Department Tel.14168
 
Specimen Retention Time:
30 days
 
 
 
Test Code:
090-70-0061

Order Name:
HPV Genotype (Cervix)

 
 
Clinical Information:
Human Papilloma Virus (HPV) infection is linked with cervical cancer. HPV can be divided into “high-risk (HR)” and “low-risk (LR)” groups on the basis of their association with cervical lesions. Therefore, it is very important to know which type of HPV is infected in patients to prevent cancer development and transmission of disease. Cervical cancer, which progresses from the precancerous stage to invasive cancer, has 7-20 years of precancerous stage; consequently early diagnosis is possible when HPV infection is suspected. High-risk HPV group may lead to the development of cervical cancer; especially, HPV16 and 18 are associated with 70% of cervical cancer case. On the other hands, low-risk HPV group including HPV6 and 11 may cause genital warts.
 
Reference Value:
Negative
 
Interpretation:
  1. This test can identify 19 high-risk HPV types (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 69, 73, 82) and also detect for 9 low-risk HPV types (6, 11, 40, 42, 43, 44, 54, 61, 70)
  2. Reliable results are dependent on adequate specimen collection, transport, storage and processing procedures.
  3. The detection of HPV is dependent on the number of organisms present in the specimen and may be affected by specimen collection methods, patient factors and stage of infection.
  4. Mutations or polymorphisms in primer- or probe-binding regions may affect detection of HPV DNA, resulting in a false negative result.
 
Clinical Reference:
Manufacturer’s package insert, AnyplexTM II HPV28 Detection, January 2019, Seegene, Inc. 138-050 Seoul, Korea